Clinical Trials on Altered Heparin Response in Peru

Total 10 results

Universidad Peruana Cayetano Heredia
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Lactoferrin for Prevention of Sepsis in Infants (NEOLACTO)

Late Onset Neonatal Sepsis

Peru
Universidad Peruana Cayetano Heredia

Completed

Pilot Study: Lactoferrin for Prevention of Neonatal Sepsis (NEOLACTO)

Sepsis

Peru
Westat
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy

Eye Abnormalities | Hearing Loss | Zika | Neurodevelopmental Abnormality | Growth Delay

Brazil, Colombia, Peru, Puerto Rico
Foundation for the National Institutes of Health
Johns Hopkins University; Aga Khan University; Penn State University; University... and other collaborators

Unknown

Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development (MAL-ED)

Immune Response | Diarrhea | Malnutrition | Wasting | Stunting | Cognitive Development

India, Pakistan, Bangladesh, Brazil, Nepal, Peru, South Africa, Tanzania
Consorci Sanitari de l'Alt Penedès i Garraf

Not yet recruiting

Benefit of a Hospital Intervention in Patients With Hepatic Steatosis (BIPEH)

Hepatic Steatosis

Spain
Synta Pharmaceuticals Corp.

Completed

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer (Enchant)

Breast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment

Spain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
GlaxoSmithKline

Completed

GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults

Sepsis

United States, Canada, France, Netherlands, Russian Federation, Taiwan, Czechia, Estonia, Spain, Sweden, Thailand, Germany, Belgium, Israel, United Kingdom, Korea, Republic of, Portugal, Finland, Latvia, New Zealand, Malaysia, South... and more
Novartis Pharmaceuticals
Incyte Corporation

Completed

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)

Cytokine Storm (Covid-19)

United States, Colombia, Turkey, Spain, United Kingdom, Germany, Peru, Russian Federation, Brazil, France, Mexico, Argentina
Asahi Kasei Pharma America Corporation

Completed

Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

Severe Sepsis | Coagulopathy

Korea, Republic of, United States, Taiwan, Netherlands, United Kingdom, Australia, Canada, Belgium, Israel, Spain, New Zealand, France, Brazil, India, Argentina, Bulgaria, Croatia, Czechia, Finland, Germany, Hungary, Peru, Russian Federation and more
Entasis Therapeutics

Completed

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex (ATTACK)

Bacteremia | Ventilator-associated Bacterial Pneumonia | Acinetobacter Baumannii-calcoaceticus Complex | Hospital-acquired Bacterial Pneumonia | Colistin Resistant ABC

United States, Belarus, Brazil, China, Greece, Hungary, India, Israel, Korea, Republic of, Lithuania, Mexico, Peru, Puerto Rico, Russian Federation, Taiwan, Thailand, Turkey

Clinical Trials on Altered Heparin Response in Peru

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations